Review Article: Potential Mechanisms of Action of Rifaximin in the Management of Irritable Bowel Syndrome With Diarrhoea

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13437
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile

Clinical Medicine Insights: Gastroenterology
Gastroenterology
2017English

Editorial: ONO-2952 in Irritable Bowel Syndrome With Diarrhoea

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Review Article: Transient Receptor Potential Channels as Possible Therapeutic Targets in Irritable Bowel Syndrome

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: ONO-2952 in Irritable Bowel Syndrome With Diarrhoea - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Screening for Bile Acid Diarrhoea in Suspected Irritable Bowel Syndrome

Gut
Gastroenterology
2014English

The Role of Diet in the Pathogenesis and Management of Irritable Bowel Syndrome (Review)

International Journal of Molecular Medicine
MedicineGenetics
2012English

Guidelines on the Management of Irritable Bowel Syndrome

Przeglad Gastroenterologiczny
Gastroenterology
2018English

Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The Confluence of Increased Permeability, Inflammation, and Pain in Irritable Bowel Syndrome

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2012English

The Place of Eluxadoline in the Management of Irritable Bowel Syndrome With Diarrhea

Therapeutic Advances in Gastroenterology
Gastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy